STOCK TITAN
  1. Home
  2. News
  3. NBTX
  4. Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Nanobiotix (NBTX) has reported its latest voting rights and share capital status as of May 31, 2025. The company disclosed that it has 47,426,851 shares outstanding. The total number of theoretical voting rights stands at 49,529,244, while the exercisable voting rights amount to 49,507,126. This regular update, required by French regulatory authorities, provides transparency regarding the company's capital structure and voting rights distribution. The disclosure complies with the French Commercial Code and the General Regulation of the French Financial Markets Authority (AMF).
Nanobiotix (NBTX) ha comunicato il suo più recente stato dei diritti di voto e del capitale sociale al 31 maggio 2025. La società ha dichiarato di avere 47.426.851 azioni in circolazione. Il numero totale di diritti di voto teorici è pari a 49.529.244, mentre i diritti di voto esercitabili ammontano a 49.507.126. Questo aggiornamento periodico, richiesto dalle autorità regolatorie francesi, garantisce trasparenza riguardo alla struttura del capitale e alla distribuzione dei diritti di voto della società. La comunicazione è conforme al Codice Commerciale francese e al Regolamento Generale dell’Autorità dei Mercati Finanziari (AMF).
Nanobiotix (NBTX) ha informado sobre su estado más reciente de derechos de voto y capital social al 31 de mayo de 2025. La compañía declaró que tiene 47.426.851 acciones en circulación. El número total de derechos de voto teóricos es de 49.529.244, mientras que los derechos de voto ejercitables ascienden a 49.507.126. Esta actualización periódica, requerida por las autoridades regulatorias francesas, proporciona transparencia sobre la estructura de capital y la distribución de los derechos de voto de la empresa. La divulgación cumple con el Código de Comercio francés y el Reglamento General de la Autoridad de Mercados Financieros (AMF).
Nanobiotix(NBTX)는 2025년 5월 31일 기준 최신 의결권 및 자본금 현황을 보고했습니다. 회사는 발행 주식 수가 47,426,851주임을 공개했습니다. 이론적 의결권 총수는 49,529,244이며, 행사 가능한 의결권은 49,507,126입니다. 이 정기 업데이트는 프랑스 규제 당국의 요구 사항에 따라 회사의 자본 구조와 의결권 분포에 대한 투명성을 제공합니다. 이 공시는 프랑스 상법과 프랑스 금융시장청(AMF)의 일반 규정을 준수합니다.
Nanobiotix (NBTX) a communiqué son dernier état des droits de vote et du capital social au 31 mai 2025. La société a déclaré détenir 47 426 851 actions en circulation. Le nombre total de droits de vote théoriques s'élève à 49 529 244, tandis que les droits de vote exerçables sont de 49 507 126. Cette mise à jour régulière, exigée par les autorités réglementaires françaises, assure une transparence sur la structure du capital et la répartition des droits de vote de l'entreprise. Cette divulgation est conforme au Code de commerce français et au Règlement général de l'Autorité des marchés financiers (AMF).
Nanobiotix (NBTX) hat seinen aktuellen Stand der Stimmrechte und des Aktienkapitals zum 31. Mai 2025 gemeldet. Das Unternehmen gab bekannt, dass 47.426.851 Aktien im Umlauf sind. Die Gesamtzahl der theoretischen Stimmrechte beträgt 49.529.244, während die ausübbaren Stimmrechte 49.507.126 betragen. Dieses regelmäßige Update, das von den französischen Aufsichtsbehörden verlangt wird, sorgt für Transparenz bezüglich der Kapitalstruktur und der Verteilung der Stimmrechte des Unternehmens. Die Offenlegung erfolgt in Übereinstimmung mit dem französischen Handelsgesetzbuch und der Allgemeinen Verordnung der französischen Finanzmarktaufsicht (AMF).
Positive
  • None.
Negative
  • None.

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)

PARIS, June 10, 2025 (GLOBE NEWSWIRE) --

Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website: www.nanobiotix.com

DateNumber of Shares
Outstanding		Total number of voting rights
Total voting rights,
theoretical1		Total voting rights,
exercisable2
May 31, 202547,426,85149,529,24449,507,126

 

About NANOBIOTIX

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.

Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations.

Nanobiotix is the owner of more than 25 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.

For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.

_____________________
1 The total number of theoretical (or “gross”) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

2 The total number of exercisable at a shareholders’ meeting (or “net”) voting rights is calculated without taking into account shares for which voting rights have been suspended as shares held in treasury by the Company. It is released in order to ensure that the public is properly informed.

Contacts

Nanobiotix
Communications Department
Brandon Owens
VP, Communications
+1 (617) 852-4835
contact@nanobiotix.com


Investor Relations Department
Ricky Bhajun
Director, Investor Relations
investors@nanobiotix.com

Media Relations

France – HARDY
Caroline Hardy
+33 06 70 33 49 50
carolinehardy@outlook.fr
Global – uncapped
Becky Lauer
+1 (646) 286-0057
uncappednanobiotix@uncappedcommunications.com
  

Attachment


FAQ

What is the current number of outstanding shares for Nanobiotix (NBTX)?

As of May 31, 2025, Nanobiotix has 47,426,851 shares outstanding.

How many voting rights does Nanobiotix (NBTX) have as of May 2025?

As of May 31, 2025, Nanobiotix has 49,529,244 theoretical voting rights and 49,507,126 exercisable voting rights.

What is the difference between theoretical and exercisable voting rights for NBTX?

Theoretical voting rights (49,529,244) include all potential votes, while exercisable voting rights (49,507,126) represent the actual votes that can be cast, excluding shares with suspended voting rights.

Where is Nanobiotix (NBTX) stock listed?

Nanobiotix is listed on both Euronext Paris (Compartment B) and Nasdaq, with the ticker symbol NBTX.
Stock NBTX logo
Nanobiotix S.A.

NASDAQ:NBTX

NBTX Rankings

#4006 Ranked by Market Cap
N/A Ranked by Dividends

NBTX Latest News

May 28, 2025
NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference
May 21, 2025
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
May 14, 2025
Voting Rights and Shares Capital of the Company
May 12, 2025
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
May 5, 2025
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer

NBTX Stock Data

194.36M
47.32M
12.79%
0.06%
Biotechnology
Healthcare
Link
France
Paris

Related Articles

Continue reading with these related stories

View All Latest News